Latest Ratings for SLB
DateFirmActionFromTo Jan 2022Exane BNP ParibasUpgradesNeutralOutperform Jan 2022Morgan StanleyMaintainsOverweight Jan 2022CitigroupMaintainsBuy
DateFirmActionFromTo Jan 2022Exane BNP ParibasUpgradesNeutralOutperform Jan 2022Morgan StanleyMaintainsOverweight Jan 2022CitigroupMaintainsBuy